MILLER GEORGE LLOYD 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Nov 9, 2020
Insider Transaction Report
Form 4
MILLER GEORGE LLOYD
Sr. VP, GC & Corp. Sec.
Transactions
- Sale
Common Stock
2020-11-06$297.28/sh−2,658$790,179→ 7,540.298 total - Exercise/Conversion
Common Stock
2020-11-06$62.30/sh+9,000$560,700→ 16,540.298 total - Sale
Common Stock
2020-11-06$296.41/sh−6,342$1,879,862→ 10,198.298 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-11-06−7,860→ 0 totalExercise: $62.30From: 2015-11-19Exp: 2025-11-19→ Common Stock (7,860 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-11-06−1,140→ 14,584 totalExercise: $62.30From: 2016-02-23Exp: 2025-11-19→ Common Stock (1,140 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $295.88 to $8296.73, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $296.91 to $297.70, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.